MEX3A and colorectal carcinoma: To explore the underlying mechanisms of MEX3A in promoting CRC pathogenesis, we performed co-immunoprecipitation (co-IP) assay and mass spectrometry analysis to screen MEX3A-interacting partners in 293T cells (Supplementary Fig. S4a).